As a stemness factor, histone methyltransferase EZH2 has the ability to regulate cell differentiation, embryonic development, and cancer development, and EZH2 silencing has been confirmed to downregulate different genes in ESCC (Karami Madani et al., 2018). The gene discussed is PRDM9; the disease is cancer.